Education
About Us
Working with TipRanks
Follow Us
Tc Biopharm (Holdings) Plc (TCBPY)
:TCBPY
TCBPY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.08 - $160.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.03K
Market Cap
$191.31K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,103,054
10 Day Avg. Volume3,904
30 Day Avg. Volume9,033
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TC Biopharm (Holdings) News
PremiumCompany Announcements
TC Biopharm Adjourns Shareholder Meeting Indefinitely
PremiumCompany Announcements
TC BioPharm Announces General Meeting to Discuss Key ResolutionsTCBPY FAQ
What was Tc Biopharm (Holdings) Plc’s price range in the past 12 months?
Tc Biopharm (Holdings) Plc lowest stock price was $0.08 and its highest was $160.00 in the past 12 months.
What is Tc Biopharm (Holdings) Plc’s market cap?
Tc Biopharm (Holdings) Plc’s market cap is $191.31K.
When is Tc Biopharm (Holdings) Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tc Biopharm (Holdings) Plc’s earnings last quarter?
Currently, no data Available
Is Tc Biopharm (Holdings) Plc overvalued?
According to Wall Street analysts Tc Biopharm (Holdings) Plc’s price is currently Overvalued.
Does Tc Biopharm (Holdings) Plc pay dividends?
Tc Biopharm (Holdings) Plc does not currently pay dividends.
What is Tc Biopharm (Holdings) Plc’s EPS estimate?
Tc Biopharm (Holdings) Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tc Biopharm (Holdings) Plc have?
Tc Biopharm (Holdings) Plc has 2,103,054 shares outstanding.
What happened to Tc Biopharm (Holdings) Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tc Biopharm (Holdings) Plc?
Currently, no hedge funds are holding shares in TCBPY
Company Description
Tc Biopharm (Holdings) Plc
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Technical Analysis
Gilead Sciences
―
Bluebird Bio
―
Fate Therapeutics
―
Adaptimmune Therapeutics
―
Immatics
―